CliffBio
small molecule

BETAMETHASONE VALERATE

BETAMETHASONE VALERATE

Loss of exclusivity—loss of exclusivity
CompanyAlembic →See this company's full patent-cliff portfolio

Drug detail

Brand nameBETAMETHASONE VALERATE
Active ingredientBETAMETHASONE VALERATE
Strength0.12%
Dosage formAEROSOL, FOAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalAugust 2024
Marketing statusRX

More from Alembic

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.